Literature DB >> 7991122

Bilineal transmission in Tourette's syndrome families.

R Kurlan1, V Eapen, J Stern, M P McDermott, M M Robertson.   

Abstract

We assessed the frequency of bilineal (from maternal and paternal sides) transmission of Tourette's syndrome (TS) in two groups of pedigrees: (1) 39 high-density families in which five or more relatives were reported to have TS, and (2) the families of 39 consecutively ascertained probands referred for evaluation of TS. We used two designations for the TS phenotype (tics, tics or obsessive-compulsive behavior [OCB]), and we attempted to verify bilineal transmission with direct examinations. For the high-density pedigrees, bilineal transmission was evident in 33% (considering tics) and 41% (considering tics or OCB) of families, which was confirmed by examination in 77% of the kindreds. For the consecutive pedigrees, bilineal transmission was seen in 15% (tics) and 26% (tics or OCB) of families, which was verified by examination in 66% of the kindreds. Both parents of the proband were affected (tics or OCB) in 38% of the high-density pedigrees and 10% of the consecutive pedigrees. For the high-density families only, the frequency of bilineal transmission appeared to be related to the proband's severity of TS, and for both pedigree groups, the frequency of both parents being affected was higher in families in which the proband's symptoms were most severe. Our findings support the contention that bilineal transmission and homozygosity are common in TS. These genetic phenomena might play a role in determining severity of illness and may explain current difficulties in localizing the gene defect by linkage analysis.

Entities:  

Mesh:

Year:  1994        PMID: 7991122     DOI: 10.1212/wnl.44.12.2336

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

2.  Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region.

Authors:  P Paschou; Y Feng; A J Pakstis; W C Speed; M M DeMille; J R Kidd; B Jaghori; R Kurlan; D L Pauls; P Sandor; C L Barr; K K Kidd
Journal:  Am J Hum Genet       Date:  2004-08-09       Impact factor: 11.025

Review 3.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

Review 4.  Advances in understanding and treatment of Tourette syndrome.

Authors:  Kevin St P McNaught; Jonathan W Mink
Journal:  Nat Rev Neurol       Date:  2011-11-08       Impact factor: 42.937

5.  Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families.

Authors: 
Journal:  Am J Hum Genet       Date:  2007-02       Impact factor: 11.025

6.  Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3.

Authors:  L Boghosian-Sell; D E Comings; J Overhauser
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

7.  Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance.

Authors:  J T Walkup; M C LaBuda; H S Singer; J Brown; M A Riddle; O Hurko
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

Review 8.  Quest for the elusive genetic basis of Tourette syndrome.

Authors:  P I Patel
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

9.  Behavior Therapy for Tourette Syndrome: A Systematic Review and Meta-analysis.

Authors:  Daryl J Wile; Tamara M Pringsheim
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

10.  Linkage analysis of Tourette syndrome in a large Utah pedigree.

Authors:  Stacey Knight; Hilary Coon; Michael Johnson; Mark F Leppert; Nicola J Camp; William M McMahon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.